Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder, is
characterised by the occurrence of pancreatic neuroendocrine tumours (P-NETs) in …

Pancreatic neuroendocrine tumours (PNETs) might occur as a non-familial isolated
endocrinopathy or as part of a complex hereditary syndrome, such as multiple endocrine …

Pancreatic neuroendocrine tumors (PNETs) are frequent and can be non-functional (NF) in
patients with multiple endocrine neoplasia type 1 (MEN1). Their identification is of clinical …

Context: Patients with multiple endocrine neoplasia type 1 (MEN1) are at high risk of
malignant pancreatic neuroendocrine tumors (pNETs). Structural imaging is typically used to …

Multiple endocrine neoplasia type 1 (MEN1)(prevalence, 1-10/100,000) is the most
important inherited pancreatic neuroendocrine tumor (pNET) syndrome causing up to 10 …

Introduction Multiple endocrine neoplasia type 1 (MEN1) is complex with regard to clinical
expressions, management, and molecular pathways. Advances are being made broadly and …

In multiple endocrine neoplasia type 1 (MEN1), nonfunctional pancreatic neuroendocrine
tumors (NF-pNETs) are the most frequently diagnosed NETs and a leading cause of MEN1 …

The better understanding of the biological behavior of multiple endocrine neoplasia type 1
(MEN1) organ manifestations and the increase in clinical experience warrant a revision of …

Multiple endocrine neoplasia type 1 (MEN1) is an inherited autosomal dominant disease
presenting with pancreatic neuroendocrine tumors (pNETs), parathyroid tumors, or pituitary …

Purpose Pancreatic neuroendocrine tumors (pNETs) are frequent in multiple endocrine
neoplasia type 1 (MEN1) syndrome. They are usually not surgically treated unless larger …